Pharmaqo SR9009 (STENABOLIC) 15mg x 60

Description

 

Classification 

SR9009 is classified as an experimental REV-ERB agonist and metabolic modulator. It is sometimes incorrectly marketed as a SARM or “exercise mimetic”, but its pharmacological target is different from androgen-receptor-modulating SARMs. 

SR9009 is also prohibited in tested sport under the World Anti-Doping Agency’s prohibited-substance framework as a metabolic modulator. 

What is Pharmaqo SR9009 (Stenabolic) 15mg x 60?

Pharmaqo SR9009 (Stenabolic) 15mg x 60 is marketed as an oral product containing a stated 15mg strength, supplied as 60 units.

The product name and stated strength do not independently establish its purity, authenticity, formulation or safety. Important information to verify includes:

• Exact active ingredient.
• Amount per tablet or capsule.
• Manufacturer and batch information.
• Expiry date.
• Regulatory status.
• Complete ingredient list.
• Storage requirements.

Products marketed as research chemicals may not be manufactured to pharmaceutical standards.

Dosage 

The 15mg label represents the stated product strength and is not an established human dose.

There is insufficient reliable evidence to establish a safe or effective SR9009 dosing schedule for humans. Published research has primarily involved experimental models rather than established therapeutic use in people. 

For this reason, online dosing protocols should not be treated as medically validated recommendations.

How Does SR9009 Work?

SR9009 acts as an agonist of REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian rhythm and metabolic regulation.

Preclinical research has investigated REV-ERB signalling in areas including:

• Cellular metabolism.
• Circadian regulation.
• Glucose metabolism.
• Lipid metabolism.
• Mitochondrial function.

However, effects demonstrated in laboratory or animal studies cannot automatically be considered proven benefits in humans. 

Benefits 

SR9009 is frequently marketed online for purposes such as:

• Fat-loss support.
• Increased endurance.
• Metabolic enhancement.
• Exercise-performance improvement.

However, there is no good clinical evidence establishing these benefits in humans. Research findings concerning metabolism and endurance largely come from preclinical models. 

Therefore, marketing claims should not be presented as established therapeutic benefits.

When Should You Take SR9009?

There is no medically established human administration schedule for SR9009.

The absence of adequate human clinical data means that a particular timing or dosing regimen cannot be recommended as safe or effective. People seeking treatment for obesity, metabolic problems or reduced exercise capacity should discuss evidence-based options with a qualified healthcare professional.

When Should You Not Take SR9009?

Because human safety information is limited, particular caution is appropriate for people who:

• Are pregnant or breastfeeding.
• Have liver or kidney disease.
• Have cardiovascular conditions.
• Have metabolic disorders.
• Take prescription medicines.
• Are undergoing treatment for another medical condition.
• Participate in tested competitive sport.

SR9009 should not be regarded as a substitute for an approved medicine.

What is the Mechanism of Pharmaqo SR9009?

SR9009 activates REV-ERB nuclear receptors, which participate in regulation of circadian-clock genes and metabolic pathways.

Activation of REV-ERB can influence transcriptional pathways associated with metabolism. Laboratory studies have reported effects on glucose and lipid metabolism, but the clinical significance of these findings in humans remains uncertain. 

Uses of SR9009 15mg

SR9009 is primarily encountered as an experimental research compound rather than an approved therapeutic medicine.

It is marketed online for claims involving:

• Body composition.
• Fat loss.
• Endurance.
• Metabolism.
• Athletic performance.

These uses are not established medical indications. There is currently insufficient human clinical evidence to establish SR9009 as an effective treatment for these purposes. 

Warnings and Precautions for SR9009

The major concern is the lack of a comprehensive human safety database. The long-term consequences of pharmacologically altering REV-ERB signalling in humans remain insufficiently understood.

Additional concerns include:

• Unknown long-term effects.
• Uncertain human pharmacokinetics.
• Variable quality of unregulated products.
• Potential contamination or incorrect labelling.
• Unknown interactions with medicines.

Athletes should also be aware that SR9009 is prohibited in tested sport.

Side Effects of Pharmaqo SR9009 15mg

A reliable human side-effect profile has not been established because SR9009 has not undergone adequate clinical evaluation.

Potential risks cannot therefore be accurately predicted from animal or laboratory studies alone.

Possible concerns may involve metabolic, cardiovascular, hepatic or other physiological systems, but the frequency and severity of such effects in humans remain uncertain.

Anyone experiencing serious or unexpected symptoms after taking an experimental compound should seek appropriate medical assessment.

Storage for Pharmaqo SR9009 15mg x 60

Follow the verified manufacturer’s storage instructions for the specific preparation. General precautions include:

• Keep the product in its original packaging.
• Keep it away from children.
• Protect it from excessive heat and moisture.
• Avoid direct sunlight.
• Check the expiry date.
• Do not use damaged packaging.
• Do not assume that correct storage guarantees product purity or safety.

Where to Buy Pharmaqo SR9009 15mg x 60?

To get Pharmaqo SR9009 (STENABOLIC) 15mg x 60   online, go to Steroid Sanctuary today to get the best deal on this medicine.

 

Frequently Asked Questions

1. What is Pharmaqo SR9009 15mg x 60?

It is marketed as a product containing SR9009 (Stenabolic) with a stated 15mg strength and 60-unit presentation. SR9009 is an experimental REV-ERB agonist and metabolic modulator.

2. Is SR9009 a SARM?

No. Although it is sometimes marketed alongside SARMs, SR9009 is a REV-ERB agonist, not a conventional selective androgen receptor modulator. 

3. Is SR9009 approved for human use?

No. SR9009 has not been established as an approved human medicine, and there is insufficient clinical evidence to establish its safety and effectiveness in humans. 

4. Is SR9009 prohibited in sport?

Yes. SR9009 is listed among prohibited metabolic modulators under the WADA framework. Athletes subject to anti-doping rules should avoid it. 

5. Is there an established safe dose of SR9009?

No. There is no adequately established human therapeutic dose. Published research does not provide a validated dosing regimen for consumer use.